{
Glenmark Pharmaceuticals Limited

Companies

}
001122334455554433221100
001122334455554433221100

emerging therapies and market dynamics for acute bacterial skin infections

DelveInsight's report on Acute Bacterial Skin and Skin-Structure Infections (ABSSSI) forecasts significant market growth by 2034, driven by rising prevalence and awareness. Key players include Glenmark Pharma and AbbVie, with therapies like Zevtera and Dalbavancin leading the charge. The report highlights a higher incidence in men and notes nearly 870,000 hospital admissions in the U.S. due to ABSSSI in 2004.
openPR.com
Merck & Co., Inc. Wockhardt Limited Pfizer Inc. Glenmark Pharmaceuticals Limited Allergan plc Novartis AG JPN FRA GBR ESP USA DEU ITA Gaurav Bora Show more
Healthcare, Market Report
19:35 23.12.2024

global bisoprolol fumarate market poised for significant growth through 2032

The Global Bisoprolol Fumarate market is projected to grow from USD 1.3 billion in 2023 to USD 2.0 billion by 2032, with a CAGR of 7%. This medication, primarily used for hypertension and heart-related conditions, is expected to see increased demand driven by regulatory changes and market dynamics across various regions, particularly in Europe and Asia-Pacific. Key players include Merck, Pfizer, and Novartis, with a focus on understanding market trends and competitive strategies.
openPR.com
United States Dollar Merck & Co., Inc. Amgen Inc. Alkem Laboratories Limited Mylan Pharmaceuticals Inc. Aurobindo Pharma Limited Teva Pharmaceutical Industries Ltd Dr. Reddy's Laboratories Limited Glenmark Pharmaceuticals Limited CIPLA LTD Sandoz Group AG Pfizer Inc. Bayer AG Hikma Pharmaceuticals PLC AstraZeneca PLC Novartis AG Torrent Pharmaceuticals Limited Sanofi IND ROU BEL HUN DNK POL IDN SGP ARE BRA ZAF FRA THA MEX CZE GBR CHL AUT SAU SWE NOR NLD USA ARG MYS SVK CAN NZL LKA JPN DEU RUS KOR CHN VNM Nidhi Bhavsar Show more
Regulatory & Legal, Market Report
13:09 16.12.2024

Global Generic Pharmaceuticals Market Sees Growth in Simple Generics and Biosimilars

India's "Pharmaceuticals Mission" aims to boost generic production, with simple generics leading the market due to cost-effectiveness and ease of manufacturing. Cardiovascular diseases drive demand, while small molecules dominate product types. Retail pharmacies remain the preferred distribution channel, and key players like Cipla and Teva are expanding their offerings.
GlobeNewswire News Room
United States Dollar Euro Fresenius Kabi AG Sanofi Aspen Pharmacare Holdings Ltd Sun Pharmaceuticals, Ltd. Aurobindo Pharma Limited Glenmark Pharmaceuticals Limited Pfizer Inc. Lupin Limited Dr. Reddy's Laboratories Limited Zydus Lifesciences Limited Teva Pharmaceuticals, Inc. Viatris Inc. Novartis AG Hikma Cipla Limited IND USA Show more
Healthcare, Market Report
16:30 04.12.2024

Glenmark Pharmaceuticals receives buy rating with target price of 1894 rupees

KR Choksey has maintained a "BUY" rating for Glenmark Pharmaceuticals with a target price of INR 1,894. The company"s revenue growth was supported by strong performance in India and Europe, although EBITDA fell short due to higher employee and other expenses. Adjusted net profit exceeded estimates, driven by lower depreciation and tax expenses, with expectations of 6.7% revenue growth and 42.5% adjusted PAT growth over FY24-FY26E.
Moneycontrol
Indian Rupee Glenmark Pharmaceuticals Limited IND KR Choksey
Finance & Economy, Market Report
07:03 19.11.2024

hsbc lowers glenmark pharma target while morgan stanley upgrades suzlon energy

HSBC has maintained a hold rating on Glenmark Pharma, reducing its target price to ₹1,600 from ₹1,660, citing a disappointing Q2 performance due to higher overheads, despite strong sales in India. Meanwhile, Morgan Stanley has upgraded Suzlon Energy, highlighting positive market sentiment. Glenmark"s future growth hinges on new launches and improved execution in the US market, with plans for significant R&D investment in the coming years.
Moneycontrol
United States Dollar HSBC Suzlon Energy Limited Morgan Stanley Glenmark Pharmaceuticals Limited IND Show more
Healthcare, Market Report
04:21 19.11.2024

markets outlook this week hero moto and glenmark in focus

Markets are set to experience notable movements this week, with particular attention on Hero Moto and Glenmark. Investors are encouraged to stay informed and receive updates on their transactions through push notifications for relevant content.
Moneycontrol
Hero MotoCorp Limited Glenmark Pharmaceuticals Limited IND
Finance & Economy, Social Media Post
04:18 18.11.2024

Glenmark Pharmaceuticals reports strong Q2 earnings with revenue growth

Glenmark Pharmaceuticals reported a PAT of Rs 354 crore for the September quarter, with consolidated total revenue from operations reaching Rs 3,433.8 crore, up from Rs 3,207.37 crore in the same period last year. Total expenses decreased slightly to Rs 3,000.64 crore compared to Rs 3,008 crore a year ago.
Moneycontrol
Indian Rupee Glenmark Pharmaceuticals Limited IND
Finance & Economy, Market Report
10:20 15.11.2024

Glenmark Pharma reports strong Q2 profit driven by India and Europe markets

Glenmark Pharmaceuticals reported a consolidated net profit of Rs 354.5 crore for Q2 FY25, rebounding from a loss of Rs 180.3 crore in the same quarter last year. Revenue from operations increased by 7.1% to Rs 3,433 crore, driven by strong performances in the Indian and European markets, particularly in cardiac and dermatology sectors. Despite a slight revenue drop in North America, the company’s EBITDA grew by 30.2% to Rs 601.9 crore, with margins at 17.5%.
@bsindia
Indian Rupee Glenmark Pharmaceuticals Limited IND Glenn Saldanha
Finance & Economy, Market Report
16:54 14.11.2024

companies report mixed q2 earnings as market sentiment adjusts

On November 14, 1,181 companies, including Hero MotoCorp, HAL, and Glenmark, are set to report their Q2 earnings, reflecting diverse sectoral trends. Eicher Motors achieved record revenue despite a slight sales volume decline, while Vodafone Idea reported a narrowed net loss amid a shrinking subscriber base. The market showed signs of recovery after recent declines, with the BSE Sensex and Nifty 50 gaining points in early trading.
@bsindia
Indian Rupee Muthoot Finance Limited Hindustan Aeronautics Ltd (HAL) Vodafone Idea Limited Glenmark Pharmaceuticals Limited Delhivery Limited Eicher Motors Limited Grasim Industries Ltd Hero MotoCorp Limited EaseMyTrip Thomas Cook (India) Limited Bharat Forge Limited IND Show more
Finance & Economy, Market Report
05:38 14.11.2024
Trending
Subcategory
Industry Trends Corporate News Startups & Entrepreneurship Global Trade Developments Government Economic Policies Retail and Consumer Goods Supply Chain Management Industry Mergers & Acquisitions Stock Market Updates Energy Sector Developments Venture Capital Investments Global Financial Events Finance Mergers & Acquisitions Central Bank Actions Cryptocurrency & Blockchain Regulations Emerging Startups Funding Rounds & Investments Inflation and Monetary Impact Private Equity Deals Market Analysis and Predictions
Countries:
USA IND CHN ARE SAU JPN TWN SGP EGY VNM GBR MEX IDN MYS THA CAN MAR KOR AUS ITA
Companies:
Apple Inc. NVIDIA Corporation Google Inc. Dell Technologies Inc. Samsung Securities Co.,Ltd. Learning Resources Inc. MGA Entertainment Inc. XPeng Inc. Toyota Motor Corp State Street Global Advisors Luxembourg SICAV - SSGA EMU ESG Screened Equity Fund European Union Bonds Taiwan Semiconductor Manufacturing Company Limited Microsoft Corporation Verizon Communications Inc. OpenAI ERC USD SLB 4,6% 01JUN25 Equinor Ventures AS Quanta Services, Inc. Gold Circuit Electronics Ltd. Unimicron Technology Corp.
Currencies:
United States Dollar Indian Rupee Chinese Yuan Euro Japanese Yen Australian Dollar United Arab Emirates Dirham British Pound Sterling New Taiwan Dollar New Zealand Dollar Vietnamese Đồng South Korean Won Egyptian Pound Thai Baht Saudi Riyal Indonesian Rupiah South African Rand Malaysian Ringgit Singapore Dollar Lebanese Pound
People:
Donald Trump Howard Lutnick Scott Bessent Jamieson Greer Chris Wright Shigeru Ishiba Joe Jurken Stephen Roachford David French Rick Woldenberg Marc Rosenberg Isaac Larian Tamer Al-sayed Yaseen Ghulam Ryosei Akazawa Hichem Djouhri Laurina Emmanuel Dylan Tey Xi Jinping Tim Cook

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.